In situ microscopy analysis reveals local innate immune response developed around Brucella infected cells in resistant and susceptible mice

PLoS Pathogens

Volumn 8, Issue 3, 2012, Pages

  Copin, Richard ^a   Vitry, Marie Alice ^a   Hanot Mambres, Delphine ^a   Machelart, Arnaud ^a   de Trez, Carl ^b   Vanderwinden, Jean Marie ^c   Magez, Stefan ^b   Akira, Shizuo ^d   Ryffel, Bernhard ^e   Carlier, Yves ^c   Letesson, Jean Jacques ^a   Muraille, Eric ^c  

^a UNIVERSITY OF NAMUR   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d OSAKA UNIVERSITY   (Japan)

^e UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12P35; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELOID DIFFERENTIATION FACTOR 88; RED FLUORESCENT PROTEIN; BIOLOGICAL MARKER; NEURONAL NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BRUCELLA MELITENSIS; BRUCELLOSIS; CHRONICITY; CONTROLLED STUDY; DENDRITIC CELL; GRANULOMA; INFECTION SENSITIVITY; MACROPHAGE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; ANIMAL; BRUCELLA; C57BL MOUSE; CELL SEPARATION; DISEASE MODEL; DISEASE PREDISPOSITION; IMMUNOLOGY; INNATE IMMUNITY; LIVER; LUNG DISEASE; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOGENICITY; PATHOLOGY; PHENOTYPE; SPLEEN;

ANIMALIA; BACTERIA (MICROORGANISMS); BRUCELLA; BRUCELLA MELITENSIS; MUS;

ANIMALS; BIOLOGICAL MARKERS; BRUCELLA; BRUCELLOSIS; CELL SEPARATION; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; IMMUNITY, INNATE; LIVER; LUNG DISEASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; PHENOTYPE; SPLEEN;

EID: 84861211003     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002575     Document Type: Article

References (62)

1. Corbel MJ, (1997) Brucellosis: An overview. Emerg Infect Dis 3: 213-221.
2. Cutler SJ, Whatmore AM, Commander NJ, (2005) Brucellosis- new aspects of an old disease. J Appl Microbiol 98: 1270-1281.
3. Godfroid J, Cloeckaert A, Liautard JP, Kohler S, Fretin D, et al. (2005) From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 36: 313-326.
4. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV, (2006) The new global map of human brucellosis. Lancet Infect Dis 6: 91-99.
5. Thirlwall RE, Commander NJ, Brew SD, Cutler SJ, McGiven JA, et al. (2008) Improving the specificity of immunodiagnosis for porcine brucellosis. Vet Res Commun 32: 209-213.
6. Pappas G, Panagopoulou P, Christou L, Akritidis N, (2006) Brucella as a biological weapon. Cell Mol Life Sci 63: 2229-2236.
7. Kortepeter MG, Parker GW, (1999) Potential biological weapons threats. Emerg Infect Dis 5: 523-527.
8. Young EJ, (1995) An Overview of Human Brucellosis. Clin Infect Dis 21: 283-289.
9. Rajashekara G, Glover DA, Krepps M, Splitter GA, (2005) Temporal analysis of pathogenic events in virulent and avirulent Brucella melitensis infections. Cell Microbiol 7: 1459-1473.
10. Copin R, De Baetselier P, Carlier Y, Letesson JJ, Muraille E, (2007) MyD88-dependent activation of B220(-)CD11b(+)LY-6C(+) dendritic cells during Brucella melitensis infection. J Immunol 178: 5182-5191.
11. Ko J, Gendron-Fitzpatrick A, Splitter GA, (2002) Susceptibility of IFN regulatory factor-1 and IFN consensus sequence binding protein-deficient mice to brucellosis. J Immunol 168: 2433-2440.
12. Murphy EA, Sathiyaseelan J, Parent MA, Zou BX, Baldwin CL, (2001) Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103: 511-518.
13. Stevens MG, Pugh GW, Tabatabai LB, (1992) Effects of Gamma-Interferon and Indomethacin in Preventing Brucella-Abortus Infections in Mice. Infect Immun 60: 4407-4409.
14. Zhan YF, Cheers C, (1993) Endogenous Gamma-Interferon Mediates Resistance to Brucella-Abortus Infection. Infect Immun 61: 4899-4901.
15. Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F, (2009) Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol 10: 943-948.
16. Kang SJ, Liang HE, Reizis B, Locksley RM, (2008) Regulation of Hierarchical Clustering and Activation of Innate Immune Cells by Dendritic Cells. Immunity 29: 819-833.
17. Spink, WW, (1956) The nature of Brucellosis Minneapolis University of Minnesota Press.
18. Shaner NC, Campbell RE, Steinbach PA, Giepmans BNG, Palmer AE, et al. (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp red fluorescent protein. Nat Biotechnol 22: 1567-1572.
19. Kohler S, Foulongne V, Ouahrani-Bettache S, Bourg G, Teyssier J, et al. (2002) The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell. Proc Natl Acad Sci U S A 99: 15711-15716.
20. Kohler S, Ouahrani-Bettache S, Layssac M, Teyssier J, Liautard JP, (1999) Constitutive and inducible expression of green fluorescent protein in Brucella suis. Infect Immun 67: 6695-6697.
21. Cesta MF, (2006) Normal structure, function, and histology of the spleen. Toxicol Pathol 34: 455-465.
22. O'Callaghan D, Cazevieille C, Allardet-Servent A, Boschiroli ML, Bourg G, et al. (1999) A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis. Mol Microbiol 33: 1210-1220.
23. Hong PC, Tsolis RM, Ficht TA, (2000) Identification of genes required for chronic persistence of Brucella abortus in mice. Infect Immun 68: 4102-4107.
24. Rolan HG, Tsolis RM, (2007) Mice lacking components of adaptive immunity show increased Brucella abortus virB mutant colonization. Infect Immun 75: 2965-2973.
25. Fernandes DM, Jiang XS, Jung JH, Baldwin CL, (1996) Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308. FEMS Immunol Med Microbiol 16: 193-203.
26. Barquero-Calvo E, Chaves-Olarte E, Weiss DS, Guzman-Verri C, Chacon-Diaz C, et al. (2007) Brucella abortus Uses a Stealthy Strategy to Avoid Activation of the Innate Immune System during the Onset of Infection. Plos One 2: e631.
27. De Trez C, Pajak B, Brait M, Glaichenhaus N, Urbain J, et al. (2005) TLR4 and Toll-IL-1 receptor domain-containing adapter-inducing IFN-beta, but not MyD88, regulate Escherichia coli-induced dendritic cell maturation and apoptosis in vivo. J Immunol 175: 839-846.
28. Zhan YF, Cheers C, (1995) Endogenous Interleukin-12 Is Involved in Resistance to Brucella-Abortus Infection. Infect Immun 63: 1387-1390.
29. Silva TMA, Costa EA, Paixao T, Tsolis RM, Santos RL, (2011) Laboratory Animal Models for Brucellosis Research. J Biomed Biotechnol 2011: 518323.
30. Martirosyan A, Moreno E, Gorvel JP, (2011) An evolutionary strategy for a stealthy intracellular Brucella pathogen. Immunol Rev 240: 211-234.
31. Golding B, Scott DE, Scharf O, Huang LY, Zaitseva M, et al. (2001) Immunity and protection against Brucella abortus. Microbes Infect 3: 43-48.
32. Moreno E, Moriyon I, (2006) The Prokaryotes. In: Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrandt E, editors. The Prokaryotes. 3 ed New York Springer pp. 315-456.
33. Baldwin CL, Parent M, (2002) Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. Vet Microbiol 90: 367-382.
34. Sugawara I, Yamada H, Kazumi Y, Doi N, Otomo K, et al. (1998) Induction of granulomas in interferon-gamma gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis. J Med Microbiol 47: 871-877.
35. Scanga CA, Bafica A, Feng CG, Cheever AW, Hieny S, et al. (2004) MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect Immun 72: 2400-2404.
36. Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, et al. (2010) Cutting Edge: Caspase-1 Independent IL-1 beta Production Is Critical for Host Resistance to Mycobacterium tuberculosis and Does Not Require TLR Signaling In Vivo. J Immunol 184: 3326-3330.
37. Seki E, Tsutsui H, Tsuji NM, Hayashi N, Adachi K, et al. (2002) Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol 169: 3863-3868.
38. Hawn TR, Smith KD, Aderem A, Skerrett SJ, (2006) Myeloid differentiation primary response gene (88)- and toll-like receptor 2-deficient mice are susceptible to infection with aerosolized Legionella pneumophila. J Infect Dis 193: 1693-1702.
39. Macedo GC, Magnani DM, Carvalho NB, Bruna-Romero O, Gazzinelli RT, et al. (2008) Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection. J Immunol 180: 1080-1087.
40. Enright FM, Araya LN, Elzer PH, Rowe GE, Winter AJ, (1990) Comparative Histopathology in Balb/C Mice Infected with Virulent and Attenuated Strains of Brucella-Abortus. Vet Immunol Immunopathol 26: 171-182.
41. Palmer MV, Cheville NF, Tatum FM, (1996) Morphometric and histopathologic analysis of lymphoid depletion in murine spleens following infection with Brucella abortus strains 2308 or RB51 or an htrA deletion mutant. Vet Pathol 33: 282-289.
42. Mense MG, Van de Verg LL, Bhattacharjee AK, Garrett JL, Hart JA, et al. (2001) Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis. Am J Vet Res 62: 398-405.
43. Akritidis N, Tzivras M, Delladetsima I, Stefanaki S, Moutsopoulos HM, et al. (2007) The liver in brucellosis. Clin Gastroenterol Hepatol 5: 1109-1112.
44. Archambaud C, Salcedo SP, Lelouard H, Devilard E, de Bovis B, et al. (2010) Contrasting roles of macrophages and dendritic cells in controlling initial pulmonary Brucella infection. Eur J Immunol 40: 3458-3471.
45. Stevens MG, Olsen SC, Pugh GW, Palmer MV, (1994) Immune and Pathological Responses in Mice Infected with Brucella-Abortus-19, Brucella-Abortus-Rb51, Or Brucella-Abortus-2308. Infect Immun 62: 3206-3212.
46. Forestier C, Moreno E, Pizarro-Cerda J, Gorvel JP, (1999) Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study. J Immunol 162: 6784-6791.
47. Billard E, Cazevieille C, Dornand J, Gross A, (2005) High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, Brucella abortus, and Brucella melitensis. Infect Immun 73: 8418-8424.
48. Pizarro-Cerda J, Meresse S, Parton RG, van der Goot G, Sola-Landa A, et al. (1998) Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect Immun 66: 5711-5724.
49. Detilleux PG, Deyoe BL, Cheville NF, (1990) Penetration and Intracellular Growth of Brucella-Abortus in Nonphagocytic Cells-Invitro. Infect Immun 58: 2320-2328.
50. Salcedo SP, Marchesini MI, Lelouard H, Fugier E, Jolly G, et al. (2008) Brucella control of dendritic cell maturation is dependent on the TIR-Containing protein btp1. Plos Pathog 4: e21.
51. Billard E, Dornand J, Gross A, (2007) Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion. Infect Immun 75: 4980-4989.
52. Ordway D, Henao-Tamayo M, Orme IM, Gonzalez-Juarrero M, (2005) Foamy macrophages within lung granulomas of mice infected with Mycobacterium tuberculosis express molecules characteristic of dendritic cells and antiapoptotic markers of the TNF receptor-associated factor family. J Immunol 175: 3873-3881.
53. Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, et al. (2008) Foamy Macrophages from Tuberculous Patients' Granulomas Constitute a Nutrient-Rich Reservoir for M-tuberculosis Persistence. Plos Pathog 4: e1000204.
54. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S, (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
55. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, et al. (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424: 743-748.
56. Mattner F, Magram J, Ferrante J, Launois P, DiPadova K, et al. (1996) Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 26: 1553-1559.
57. Dalton DK, Pittsmeek S, Keshav S, Figari IS, Bradley A, et al. (1993) Multiple Defects of Immune Cell-Function in Mice with Disrupted Interferon-Gamma Genes. Science 259: 1739-1742.
58. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, et al. (1992) Rag-1-Deficient Mice Have No Mature Lymphocytes-B and Lymphocytes-T. Cell 68: 869-877.
59. Tibor A, Wansard V, Bielartz V, Delrue RM, Danese I, et al. (2002) Effect of omp10 or omp19 deletion on Brucella abortus outer membrane properties and virulence in mice. Infect Immun 70: 5540-5546.
60. Dozot M, Boigegrain RA, Delrue RM, Hallez R, Ouahrani-Bettache S, et al. (2006) The stringent response mediator Rsh is required for Brucella melitensis and Brucella suis virulence, and for expression of the type IV secretion system virB. Cell Microbiol 8: 1791-1802.
61. Nijskens C, Copin R, De Bolle X, Letesson JJ, (2008) Intracellular rescuing of a B-melitensis 16M virB mutant by co-infection with a wild type strain. Microb Pathog 45: 134-141.
62. De Trez C, Magez S, Akira S, Ryffel B, Carlier Y, et al. (2009) iNOS-Producing Inflammatory Dendritic Cells Constitute the Major Infected Cell Type during the Chronic Leishmania major Infection Phase of C57BL/6 Resistant Mice. Plos Pathog 5: e1000494.